Bicycle Therapeutics (BCYC) EBIT (2018 - 2026)
Bicycle Therapeutics posted quarterly EBIT of -$65.5 million for Q1 2026, up 6.73% year-on-year from -$61.4 million in Q1 2025, and down 165.02% on a QoQ basis from -$24.7 million in Q4 2025.
Bicycle Therapeutics (BCYC) has 9 years of EBIT data on file, last reported at -$65.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 6.73% year-over-year to -$65.5 million; the trailing twelve-month figure through Mar 2026 stood at -$242.3 million (up 2.42% YoY), and the FY2025 full-year result was -$247.1 million, down 17.72% from the prior year.
- EBIT for Q1 2026 stood at -$65.5 million, down from -$24.7 million in the prior quarter.
- Across five years, EBIT topped out at -$24.7 million in Q4 2025 and bottomed at -$86.6 million in Q2 2025.
- The 5-year median for EBIT is -$46.6 million (2024), against an average of -$48.8 million.
- Peak annual rise in EBIT reached 63.48% in 2025, while the deepest fall reached 121.35% in 2025.
- A 5-year view of EBIT shows it stood at -$32.2 million in 2022, then slumped by 68.37% to -$54.2 million in 2023, then decreased by 24.76% to -$67.7 million in 2024, then soared by 63.48% to -$24.7 million in 2025, then tumbled by 165.02% to -$65.5 million in 2026.
- The last three EBIT figures came in at -$65.5 million (Q1 2026), -$24.7 million (Q4 2025), and -$65.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | -65.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.48 Mn |
| Dec 31, 2025 | -24.71 Mn |
| Sep 30, 2025 | -65.55 Mn |
| Jun 30, 2025 | -86.60 Mn |
| Mar 31, 2025 | -70.20 Mn |
| Dec 31, 2024 | -67.66 Mn |
| Sep 30, 2024 | -63.85 Mn |
| Jun 30, 2024 | -46.65 Mn |
| Mar 31, 2024 | -31.72 Mn |
| Dec 31, 2023 | -54.24 Mn |
| Sep 30, 2023 | -50.80 Mn |
| Jun 30, 2023 | -43.11 Mn |
| Mar 31, 2023 | -41.80 Mn |
| Dec 31, 2022 | -32.21 Mn |
| Sep 30, 2022 | -29.76 Mn |
| Jun 30, 2022 | -27.30 Mn |
| Mar 31, 2022 | -27.38 Mn |
| Dec 31, 2021 | -18.02 Mn |
| Sep 30, 2021 | -14.29 Mn |
| Jun 30, 2021 | -17.28 Mn |
| Mar 31, 2021 | -16.02 Mn |
| Dec 31, 2020 | -17.06 Mn |
| Sep 30, 2020 | -10.68 Mn |
| Jun 30, 2020 | -12.58 Mn |
| Mar 31, 2020 | -11.64 Mn |
| Dec 31, 2019 | -4.76 Mn |
| Sep 30, 2019 | -10.25 Mn |
| Jun 30, 2019 | -7.99 Mn |
| Mar 31, 2019 | -3.29 Mn |
| Dec 31, 2018 | -7.54 Mn |
| Sep 30, 2018 | -6.36 Mn |
| Jun 30, 2018 | -4.96 Mn |
| Mar 31, 2018 | -2.93 Mn |